Positive skin prick tests (Skin prick test > 3 mm)
|
Number (%)
|
n
|
Number (%)
|
n
|
Any of 11 inhalant and food allergensa
|
151 (36.9%)
|
409
|
173 (45.3%)
|
382
|
Inhalant allergenb
|
145 (35.4%)
|
409
|
170 (44.5%)
|
382
|
Ingested allergenc
|
25 (6.1%)
|
409
|
30 (7.9%)
|
382
|
House dust mite (HDM)
|
120 (29.3%)
|
409
|
137 (35.9%)
|
382
|
Ryegrass
|
43 (10.5%)
|
409
|
69 (18.1%)
|
381
|
Grass mix
|
43 (10.5%)
|
409
|
51 (13.4%)
|
380
|
Alternaria tenuis
|
29 (7.1%)
|
409
|
43 (9.7%)
|
380
|
Cockroach
|
18 (4.4%)
|
409
|
18 (4.7%)
|
381
|
Cat dander
|
16 (4.5%)
|
409
|
23 (4.5%)
|
382
|
Cytokines and total IgE
|
HDM specific IL-5 responder
|
78 (25.4%)
|
307
|
78 (30.23%)
|
258
|
HDM specific IL-10 responder
|
150 (51.1%)
|
293
|
121 (46.7%)
|
281
|
Total IgE (kU/L)
|
Median:70 IQR(25–186)
|
341
|
Median:118 IQR(37–392)
|
303
|
Questionnaire variables
|
Doctor-diagnosed asthma
|
114 (27.2%)
|
418
|
119 (28.40%)
|
419
|
Ever Doctor-diagnosed Asthma
|
141 (33.6%)
|
419
|
170 (40.5%)
|
419
|
Wheeze in last 12 months
|
130 (31.1%)
|
418
|
114 (27.2%)
|
419
|
Wheeze in the last 12 months + asthma diagnosis
|
83 (19.8%)
|
418
|
91 (21.7%)
|
419
|
Cough in last 12 months at least four times
|
143 (34.2%)
|
418
|
101 (24.1%)
|
419
|
Doctor diagnosed allergic rhinitis
|
23 (5.5%)
|
418
|
52 (12.4%)
|
419
|
Doctor diagnosed eczema
|
119 (28.47%)
|
418
|
129 (30.7%)
|
419
|
Eczema in the last 12 months
|
92 (22.1%)
|
416
|
58 (14.3%)
|
405
|
Spirometry
|
Mean (SD)
|
N
|
Mean (SD)
|
N
|
FEV1 pre bronchodilator % predicted
|
115.8% (17.7)
|
328
|
100.1% (11.8)
|
396
|
FVC pre bronchodilator % predicted
|
124.3% (20.3)
|
323
|
98.9% (11.6)
|
390
|
FEV1 post bronchodilator % predicted
|
120.0% (18.4)
|
323
|
105.9% (11.1)
|
392
|
FVC post bronchodilator % predicted
|
128.2% (19.7)
|
323
|
99.5% (10.6)
|
386
|
FEV1/FVC ratio pre bronchodilator
|
0.93 (0.06)
|
328
|
0.89 (0.07)
|
391
|
FEV1/FVC ratio post bronchodilator
|
0.93 (0.06)
|
328
|
0.93 (0.05)
|
387
|
pre Peak Expiratory Flow (PEF)
|
2.28 (0.47)
|
326
|
203 (37.1)
|
410
|
post Peak Expiratory Flow (PEF)
|
2.33 (0.53)
|
321
|
211 (38.2)
|
406
|
Pre forced expiratory flow at 50% vital capacity (FEF50)
|
1.60 (0.41)
|
326
|
2.18 (0.55)
|
410
|
Post forced expiratory flow at 50% vital capacity(FEF50)
|
1.77 (0.51)
|
321
|
2.51 (0.53)
|
406
|
Pre forced expiratory flow at mid-expiratory phase(FEF25–75)
|
1.46 (0.37)
|
326
|
2.11(0.43)
|
410
|
Post forced expiratory flow at mid-expiratory phase(FEF25–75)
|
1.61 (0.46)
|
321
|
2.35 (0.43)
|
406
|
Exposure
|
Mean (SD)
|
N
|
Mean (SD)
|
N
|
Weighted road density within 50 m of home, where one unit represents 100 m local road or 33.3 m of motorway
|
1.04 (0.6)
|
390
|
1.1 (0.6)
|
389
|
Mean Omega3:Omega6 ratio (fish oil supplemented vs. non-supplemented (p-value significance))
|
0.18 vs. 0.14(***)
|
367
|
0.15 vs. 0.15(NS)
|
314
|
|
Number (%)
|
N
|
Number (%)
|
N
|
Fish oil supplementation at age 5 years
|
214 (51%)
|
419
|
214 (51%)
|
419
|
Urban environment
|
392 (93.7%)
|
418
|
421 (91.9%)
|
458
|